Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAltitude Group Regulatory News (ALT)

Share Price Information for Altitude Group (ALT)

Share Price is delayed by 15 minutes
Get Live Data
27.50    0.00 (0.00%)
Bid:
26.00
Ask:
29.00
Spread: 3.00 (11.538%)
Market Cap: £20.11m
ALT Live PriceLast checked at - London Stock Exchange

Intraday Altitude Group Share Chart

Grant of Options

25 Jun 2019 07:00

RNS Number : 2667D
Altitude Group PLC
25 June 2019
 

25 June 2019

ALTITUDE GROUP PLC

("Altitude", the "Group" or the "Company")

Grant of Options

Altitude Group plc (AIM: ALT), the operator of a leading marketplace for personalised products, announces that it has granted 1,060,000 options in aggregate over ordinary shares of 0.4p each ("Ordinary Shares") to certain directors of the Group (the "Options").

 

The Options have been granted in amounts of 560,000 and 500,000 to Deborah Wilkinson (Chief Operating Officer) and Keith Edelman (Non-Executive Director) (together the "Option Recipients") respectively. The Options are exercisable at a price of 105p, being the volume weighted average share price for the 30 days preceding the date of this announcement. Deborah Wilkinson's options are split into two equal amounts; the first half accrue and vest on a lineal basis across 36 months from the date of grant and the second half vest in three equal tranches based on the Group achieving share price targets of 200p, 250p and 300p. Keith Edelman's options vest in three equal tranches based upon the Group achieving share price targets of 200p, 250p and 300p.

 

Following grant, the Options represent the only options over Ordinary Shares that Deborah Wilkinson and Keith Edelman will be interested in. In aggregate the Options, when added to other employee options already in existence, will result in employee options equivalent to 6.09 per cent. of the issued share capital of the Company being in existence.

 

The Options are being granted to align all of the Board on similar incentive packages and this will be the last time the Company issues significant option packages to a Non-Executive Director, either current or future.

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014 of the Market Abuse Regulation

 

Enquiries:

Altitude Group plc - via Instinctif Partners 020 7457 2020

Nichole Stella, Chief Executive Officer

Graeme Couturier, Chief Financial Officer

Peter Hallett, Non-Executive Chairman

 

finnCap Ltd 020 7220 0500

Jonny Franklin-Adams / Scott Mathieson (Corporate Finance)

Richard Chambers (ECM)

 

Instinctif Partners 020 7457 2020

Matthew Smallwood

Chantal Woolcock

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Deborah Wilkinson

2.

Reason for the Notification

a)

Position/status

PDMR: Chief Operational Officer

b)

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Altitude Group plc

b)

LEI

213800VACSTYYSI39R89

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 0.4p

 

Identification code

GB00B0LSFV82

b)

Nature of the transaction

Grant of Options over Ordinary Shares

c)

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

105 pence

560,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

As above

e)

Date of the transaction

24 June 2019

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Keith Edelman

2.

Reason for the Notification

a)

Position/status

PDMR: Non-Executive Director

b)

Initial notification/Amendment

Initial notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Altitude Group plc

b)

LEI

213800VACSTYYSI39R89

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Options over ordinary shares of 0.4p

 

Identification code

GB00B0LSFV82

b)

Nature of the transaction

Grant of Options over Ordinary Shares

c)

Price(s) and volume(s)

Exercise Price(s)

Volume(s)

105 pence

500,000

 

d)

Aggregated information:

· Aggregated volume

· Price

 

As above

e)

Date of the transaction

24 June 2019

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFZLLLKQFZBBE
Date   Source Headline
3rd Jul 20267:00 amRNSDirectorate Changes
30th Jun 20267:00 amRNSAppointment of Non-Executive Director
18th Jun 202611:59 amRNSHolding(s) in Company
11th Jun 20267:00 amRNSDirector/PDMR Dealing
8th Jun 20267:00 amRNSDirector/PDMR Shareholding
1st Jun 20268:31 amRNSExercise & Grant of Options and TVR
17th Apr 20267:00 amRNSBoard Role Change
14th Apr 20263:25 pmRNSDirector/PDMR Dealing
9th Apr 202612:00 pmRNSDirector/PDMR Dealing
31st Mar 20267:00 amRNSTrading Update
5th Mar 20263:39 pmRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSAppointment of Independent Non-Executive Director
10th Feb 202612:32 pmRNS-RAppointment of Chief Commercial Officer
4th Feb 20267:00 amRNSAppointment of Nominated Adviser and Sole Broker
19th Jan 20261:33 pmRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
23rd Dec 20257:00 amRNSPDMR Dealing
1st Dec 20259:01 amRNSPDMR Dealing
28th Nov 20257:00 amRNSChange of Registered Office
27th Nov 20254:57 pmRNSCorrection: Exercise & Grant of Options and TVR
27th Nov 20257:30 amRNSExercise & Grant of Options, PDMR Dealings and TVR
27th Nov 20257:00 amRNSInterim Results
11th Nov 20257:00 amRNSTrading Update, Board Change and Notice of Results
30th Oct 20257:00 amRNSHolding(s) in Company
26th Sep 20257:00 amRNSResult of AGM
12th Sep 20257:00 amRNSDirector/PDMR Dealing
11th Sep 20257:00 amRNSDirector/PDMR Dealing
10th Sep 20257:00 amRNSDirector/PDMR Dealing
8th Sep 20257:00 amRNSDirector/PDMR Dealing
5th Sep 20257:00 amRNSDirector/PDMR Dealing
15th Aug 20254:20 pmRNSChange of Venue for the 2025 AGM
7th Aug 20257:00 amRNSAudited Annual Results and Notice of AGM
30th Jul 20257:00 amRNSNotice of Results
15th Jul 20257:00 amRNSBoard Changes and Trading Update
23rd Jun 20257:00 amRNSAppointment of CFO
17th Jun 20257:00 amRNSBoard Change and Trading Update
15th May 20257:00 amRNSGrant of Options and PDMR Dealings
9th May 20255:50 pmRNSDirector/PDMR Dealing
9th Apr 20257:00 amRNSExercise of Options, Director Dealings and TVR
1st Apr 20257:00 amRNSDirector/PDMR Dealing
31st Mar 20257:00 amRNSTrading Update and New University Contract Awards
28th Mar 20257:00 amRNSChange of Registered Office
11th Mar 20257:00 amRNSDirector/PDMR Dealings
6th Mar 20257:00 amRNSDirectorate Change
3rd Dec 20247:00 amRNSInterim Results
15th Nov 20247:00 amRNSTrading Update and Notice of Results
8th Oct 20244:04 pmRNSHolding(s) in Company
23rd Sep 20244:47 pmRNSResult of AGM
6th Sep 202412:30 pmRNSPosting of Annual Report and Notice of AGM
30th Jul 20247:00 amRNSAudited Annual Results and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.